Your browser doesn't support javascript.
loading
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial.
Susai, Subash Raj; Föcking, Melanie; Mongan, David; Heurich, Meike; Coutts, Fiona; Egerton, Alice; Whetton, Tony; Winter-van Rossum, Inge; Unwin, Richard D; Pollak, Thomas A; Weiser, Mark; Leboyer, Marion; Rujescu, Dan; Byrne, Jonah F; Gifford, George W; Dazzan, Paola; Koutsouleris, Nikolaos; Kahn, René S; Cotter, David R; McGuire, Philip.
Afiliação
  • Susai SR; Department of Psychiatry, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Föcking M; Department of Psychiatry, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Mongan D; Department of Psychiatry, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Heurich M; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
  • Coutts F; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Egerton A; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Whetton T; School of Veterinary Medicine, School of Biosciences and Medicine, University of Surrey, Guildford, GU2 7XH, UK.
  • Winter-van Rossum I; Department of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Unwin RD; Stoller Biomarker Discovery Centre and Division of Cancer Sciences, School of Medicine, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9NY, UK.
  • Pollak TA; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Weiser M; Stanley Medical Research Institute, Kensington, MD, USA.
  • Leboyer M; Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Rujescu D; Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires « H. Mondor ¼, DMU IMPACT, FHU ADA¨T, INSERMU955, IMRB, Translational Neuropsychiatry laboratory, F-94010 Creteil, France.
  • Byrne JF; University Clinic and Outpatient Clinic for Psychiatry, Psychotherapy and Psychosomatics, Martin Luther University of Halle-Wittenberg, Halle, Germany.
  • Gifford GW; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
  • Dazzan P; Department of Psychiatry, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Koutsouleris N; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Kahn RS; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Cotter DR; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • McGuire P; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Schizophr Bull ; 49(4): 893-902, 2023 07 04.
Article em En | MEDLINE | ID: mdl-36916850
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Antipsicóticos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Schizophr Bull Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Antipsicóticos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Schizophr Bull Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda